Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,204 | 3,288 | 5,025 | 2,827 | 316 |
| Receivables | N/A | N/A | N/A | N/A | 350 |
| TOTAL | $5,619 | $3,823 | $5,337 | $3,199 | $1,136 |
| Non-Current Assets | |||||
| Investments And Advances | 1,091 | 1,122 | 1,344 | 1,534 | 1,728 |
| Intangibles | 4 | 4 | 4 | 4 | 4 |
| TOTAL | $1,094 | $1,125 | $1,348 | $1,538 | $1,732 |
| Total Assets | $6,713 | $4,949 | $6,684 | $4,737 | $2,867 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 318 | 317 | 178 | 127 | 82 |
| Accrued Expenses | 501 | 335 | 375 | 478 | 409 |
| Other current liabilities | N/A | N/A | N/A | N/A | 8 |
| TOTAL | $829 | $672 | $563 | $653 | $528 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $829 | $672 | $563 | $653 | $528 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 256 | 256 | 169 | 162 | 49 |
| Common Shares | 6 | 4 | 4 | 2 | 1 |
| Retained earnings | -79,925 | -77,733 | -75,274 | -68,798 | -66,878 |
| TOTAL | $5,884 | $4,277 | $6,122 | $4,084 | $2,339 |
| Total Liabilities And Equity | $6,713 | $4,949 | $6,684 | $4,737 | $2,868 |